Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) SVP Bosch John Roderick Ten sold 2,834 shares of the business’s stock in a transaction on Monday, October 5th. The stock was sold at an average price of $105.15, for a total transaction of $297,995.10. Following the completion of the sale, the senior vice president directly owned 19,385 shares of the company’s stock, valued at $2,038,332.75. This represents a 12.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Bosch John Roderick Ten also recently made the following trade(s):
- On Thursday, September 24th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total value of $169,920.00.
- On Monday, September 21st, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $106.61, for a total value of $150,959.76.
- On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $97.54, for a total value of $138,116.64.
- On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total value of $141,700.00.
- On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total value of $131,582.62.
Billiontoone Trading Down 4.2%
Billiontoone stock traded down $4.19 during trading hours on Wednesday, reaching $95.75. The company had a trading volume of 679,799 shares, compared to its average volume of 656,006. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The company has a 50-day moving average price of $105.26 and a 200 day moving average price of $100.66. The firm has a market cap of $4.52 billion and a price-to-earnings ratio of 136.79. Billiontoone, Inc. has a 12-month low of $61.96 and a 12-month high of $150.44.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Zacks Research raised shares of Billiontoone from a “strong sell” rating to a “hold” rating in a research note on Friday, October 2nd. Guggenheim increased their target price on shares of Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Weiss Ratings restated a “sell (d+)” rating on shares of Billiontoone in a report on Friday, September 18th. Finally, BTIG Research lowered their price target on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, August 6th. Seven analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $126.25.
Get Our Latest Stock Analysis on Billiontoone
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the stock. Family Legacy Financial Solutions LLC bought a new stake in shares of Billiontoone during the 3rd quarter valued at about $53,000. MCF Advisors LLC increased its position in shares of Billiontoone by 330.8% during the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock valued at $54,000 after buying an additional 344 shares during the period. Integrated Wealth Concepts LLC bought a new position in Billiontoone in the second quarter worth about $29,000. Thrive Wealth Management LLC purchased a new stake in Billiontoone in the second quarter worth about $240,000. Finally, Jasper Ridge Partners L.P. purchased a new stake in Billiontoone in the second quarter worth about $615,000.
About Billiontoone
BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.
BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.
Read More
- Five stocks we like better than Billiontoone
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
